Convalescent Plasma to Stem Coronavirus (CSSC-001) (CSSC-001)
Donald Forthal
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 6 of 9 Results
Study of Efficacy and Safety of MAS825 in Patients With COVID-19 (MAS-COVID)
Richard Lee
- OPEN TO ACCRUAL
Study to Evaluate the Safety, PK, and Efficacy of TAK-671 for the Treatment of Coronavirus Disease
Alpesh Amin
- OPEN TO ACCRUAL
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)
Donald Forthal
- OPEN TO ACCRUAL
Safety and Antiviral Activity of BLD-2660 in Hospitalized Subjects with Recently Diagnosed COVID-19
Alpesh Amin
- OPEN TO ACCRUAL
PUL-04 Inhalation Solution in Reducing the Infection Rate and Progression to COVID-19
Alpesh Amin
- OPEN TO ACCRUAL